• About us
• Contact

Advertisement

Person › Details

Thierry Abribat (Alizé Pharma SAS)

Abribat, Thierry (Alizé Pharma 2007– President + Founder)

 

	Organisation	Alizé Pharma SAS
	Group	Alizé Pharma (Group)
	Product	AZP-01 (Alizé Pharma)
	Product 2	pegcrisantaspase (AZP-02)

Record changed: 2024-03-20

Advertisement

More documents for Thierry Abribat

• [1] Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA....
• [2] Amolyt Pharma SAS. (2/4/22). "Press Release: Amolyt Pharma Selected for the French Tech 120 Program". Lyon & Cambridge, MA....
• [3] Amolyt Pharma SAS. (9/16/21). "Press Release: Amolyt Pharma Announces $80 Million Series B Financing led by Sectoral Asset Management and Andera Partners". Lyon & Cambridge, MA....
• [4] Amolyt Pharma SAS. (12/8/20). "Press Release: Amolyt Pharma Announces Research Collaboration with PeptiDream". Lyon & Newton, MA....
• [5] Amolyt Pharma SAS. (6/8/20). "Press Release: Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage". Lyon & Newton, MA....
• [6] Amolyt Pharma SAS. (6/2/20). "Press Release: Alizé Pharma 3 Announces Rebranding to Amolyt Pharma, Reflecting a Strategic Focus on Building and Advancing a Portfolio of Therapeutic Peptides for Rare Endocrine and Metabolic Diseases". Lyon & Newton, MA....
• [7] Alizé Pharma. (7/31/19). "Press Release: Alizé Pharma 3 Raises €67 million ($75 million) in Series A from a Strong International Syndicate". Lyon....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.